These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6228475)

  • 1. Constituents of HBs particle: characterization and purity of HBsAg in "HEVAC B".
    Gerfaux G; Platel A; Adamowicz P; Mazert MC
    Dev Biol Stand; 1983; 54():45-52. PubMed ID: 6228475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis B vaccine: characterization of the polypeptides of hepatitis B surface antigen (author's transl)].
    Barin F; André M; Coursaget P; Gutman N; Hubert M; Goudeau A; Maupas P
    Ann Microbiol (Paris); 1979; 130 A(4):505-10. PubMed ID: 507623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large scale purification of hepatitis B surface antigen (HBsAg).
    Barin F; André M; Goudeau A; Coursaget P; Maupas P
    Ann Microbiol (Paris); 1978 Jul; 129B(1):87-100. PubMed ID: 718020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and potency aspects in the preparation of an experimental HBsAg vaccine.
    Thomssen R; Gerlich WH; Böttcher U; Legler K; Ritter S; Stibbe W; Weinmann W; Klinge O; Pfeifer U
    Dev Biol Stand; 1983; 54():23-31. PubMed ID: 6228464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical characteristics of a vaccine against hepatitis B].
    Adamowicz P; Yaniv M; Platel A; Muller L; Croissant O; Prunet P
    C R Seances Acad Sci III; 1981 Jan; 292(4):373-8. PubMed ID: 6781788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of vaccinated infants born to HBsAg-positive mothers with different hepatitis B vaccines and doses.
    Kuru U; Turan O; Kuru N; Sağlam Z; Alver A
    Turk J Pediatr; 1995; 37(2):93-102. PubMed ID: 7597774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.
    Yamamoto H; Satoh T; Kiyohara T; Totsuka A; Moritsugu Y
    Biologicals; 1997 Dec; 25(4):373-80. PubMed ID: 9467033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
    Zhou Z; Chen WS; Zhang HH; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccine in developing countries: problems and prospects.
    Ayoola EA
    IARC Sci Publ; 1984; (63):297-305. PubMed ID: 6242148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity to hepatitis B surface antigen in man.
    Hanson RG; Hoofnagle JH; Minuk GY; Purcell RH; Gerin JL
    Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) and intradermal hepatitis B vaccination.
    Nagafuchi S; Kashiwagi S; Hayashi J; Katsuta H; Ikematsu H; Harada M
    Fukuoka Igaku Zasshi; 2004 Dec; 95(12):305-13. PubMed ID: 15732372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advantages of spectrophotometric reading of ELISA plates for determination of the HBs/anti-HB system].
    Taliani G; Palombo G; Tonelli MG; Franco E
    Boll Soc Ital Biol Sper; 1981 Nov; 57(21):2111-5. PubMed ID: 7039638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent.
    Kondo R; Feitelson MA; Strayer DS
    Gene Ther; 1998 May; 5(5):575-82. PubMed ID: 9797861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.
    Tuaillon E; Tabaa YA; Petitjean G; Huguet MF; Pajeaux G; Fondere JM; Ponseille B; Ducos J; Blanc P; Vendrell JP
    J Immunol Methods; 2006 Aug; 315(1-2):144-52. PubMed ID: 16959261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of hepatitis B vaccine in neonates: induction of an anti-HBs immune response and interruption of maternal HBsAg transmission].
    Wang YJ
    Zhonghua Yi Xue Za Zhi; 1984 Dec; 64(12):741-4, 792. PubMed ID: 6242233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.